Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
[DISCLOSURE] Alpha Holdings (117670) said on Sept. 12 that it will acquire a total of 4.02 million shares worth 5.74 billion won (US$5.18 million) of US-based Viral Gene to advance overseas and participate in its management. Alpha Holdings will own 25.1 percent stake, making it the second-largest shareholder of Viral Gene.
Its biotechnology subsidiary Alpha Biolabs has acquired 2.68 million shares, which amount to 6.7 million in total.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Its biotechnology subsidiary Alpha Biolabs has acquired 2.68 million shares, which amount to 6.7 million in total.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
